financetom
Business
financetom
/
Business
/
Oil Rises as Supplies Remain Tight on OPEC+ Cuts, Cutting Into Inventories
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Oil Rises as Supplies Remain Tight on OPEC+ Cuts, Cutting Into Inventories
Mar 28, 2024 6:22 AM

09:00 AM EDT, 03/28/2024 (MT Newswires) -- Oil prices rose early on Thursday following two losing sessions on expectations global inventories will continue to wane through the second quarter on OPEC+ production cuts and Ukrainian attacks on Russian refineries.

West Texas Intermediate crude oil for May delivery was last seen up US$1.32 to US$82.67 per barrel, while May Brent crude, the global benchmark, was up US$1.33 to US$87.42.

OPEC's the Joint Monitoring Ministerial Committee will meet next week, though no change to production quotas is expected as OPEC+'s 2.2-million barrels per day of voluntary production cuts are likely to be in place until at least the end of June and could be further extended, though a decision is not expected until a June ministerial meeting.

"There is now a solid consensus that global oil inventories will deplete throughout the year as demand is at unprecedented levels and OPEC+ appears to stick with its self-imposed output constraints - at least until June," PVM Oil Associates noted.

Ukrainian attacks on Russian refineries are supporting product prices, keeping gasoline futures near six-month highs as Russian exports are cut by the damage.

"We now count 5 refineries facing significant throughput disruptions, with our estimates for downed refining capacity rising to 13% of Russia's total. These attacks seem to be serving the twin purposes of partially denying the Russian frontlines diesel as well as reducing Russia's essential energy revenue to fund the war. Preliminary estimates already show aggregate Russian refinery runs in March down 650 kb/d y/y," Helima Croft, Head of Global Commodity Strategy and MENA Research at RBC Capital Markets, wrote.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Firefly Aerospace Increases IPO Price Range to $41-$43
Firefly Aerospace Increases IPO Price Range to $41-$43
Aug 4, 2025
01:42 PM EDT, 08/04/2025 (MT Newswires) -- Firefly Aerospace (FLY) said in a Monday filing that it is increasing the expected price of its initial public offering of 16.2 million shares to between $41 and $43 apiece from the previous price range of $35 to $39. Net proceeds will be used to repay outstanding borrowings under a credit agreement, to...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
BRIEF-Firefly Aerospace Sees IPO Price Range Between $41.00 And $43.00 Per Share
BRIEF-Firefly Aerospace Sees IPO Price Range Between $41.00 And $43.00 Per Share
Aug 4, 2025
Aug 4 (Reuters) - Firefly Aerospace Inc: * FIREFLY AEROSPACE INC - IPO PRICE RANGE BETWEEN $41.00 AND $43.00 PER SHARE - SEC FILING Source text: Further company coverage: ...
Praxis' Epilepsy Treatment Shows Promise With Decreased Seizures
Praxis' Epilepsy Treatment Shows Promise With Decreased Seizures
Aug 4, 2025
Praxis Precision Medicines, Inc. ( PRAX ) stock experienced a volatile trading session on Monday, after the company announced positive topline results from its Phase 2 RADIANT study evaluating vormatrigine in patients with focal onset seizures and generalized epilepsy. The stock initially surged on the news, but then reversed course and is currently trading down approximately 9%. The central nervous...
Copyright 2023-2026 - www.financetom.com All Rights Reserved